financetom
Business
financetom
/
Business
/
Essel Group finally sells two tollways to NIIF
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Essel Group finally sells two tollways to NIIF
Nov 2, 2020 6:51 AM

The National Investment and Infrastructure Fund (NIIF) on Monday said it has acquired two assets – Devanahalli and Dichpally tollways – from Essel Group, marking its entry into the roads and highways sector. The deal size was not disclosed by NIIF.

The acquisition is done through the NIIF Master Fund, and the projects will be managed by Athaang Infrastructure, NIIF’s proprietary roads platform backed by a team of experienced professionals with rich domain expertise in the transportation sector, it said in a statement.

Subhash Chandra’s debt-laden Essel Grouphas been in talks with NIIF to sell these assets since last year for an estimated Rs 1,500-1,800 crore. Essel Devanahalli Tollway is a strategic arterial 22-km six-lane toll road in Karnataka, connecting Bengaluru city and the airport and is a part of NH44 (erstwhile NH7). It has been in operation for over six years. Essel Dichpally Tollway is a 60-km four-lane toll road in Telangana and has been in operation for over seven years, connecting Hyderabad and Nagpur.

The NIIF Master Fund has also anchored platforms in the ports and logistics, renewables, and energy-smart meter sectors, it said. Vinod Giri, managing partner at NIIF said this is the first investment that the fund has made in the roads sector.

” Athaang will invest in strategic assets and develop a portfolio including mature operational assets, annuities/hybrid annuities, large size expressways and highways with greenfield and brownfield expansion requirements,” he said. NIIF is a collaborative investment platform for international and domestic investors, anchored by the Centre and manages over USD 4.3 billion of equity capital commitments across its three funds – master fund, fund of funds and strategic opportunities fund. Essel Infraprojects has 14 road projects in its portfolio, of which six are under the hybrid annuity model.

Last year, it had placed six road projects, two operating transmission lines and solar power assets on the block to repay the bulk of Essel Group’s debt. So far, the company has sold a part of its solar power portfolio.

First Published:Nov 2, 2020 3:51 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Suncoke Energy Insider Sold Shares Worth $870,577, According to a Recent SEC Filing
Suncoke Energy Insider Sold Shares Worth $870,577, According to a Recent SEC Filing
Mar 14, 2024
03:46 PM EDT, 03/14/2024 (MT Newswires) -- Michael G Rippey, Director, Chief Executive Officer, on March 13, 2024, sold 78,714 shares in Suncoke Energy ( SXC ) for $870,577. Following the Form 4 filing with the SEC, Rippey has control over a total of 342,359 shares of the company, with 342,359 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1514705/000162828024011195/xslF345X03/wk-form4_1710445259.xml Price: 10.74, Change:...
Cleveland-Cliffs considering US Steel bid, Bloomberg News reports
Cleveland-Cliffs considering US Steel bid, Bloomberg News reports
Mar 14, 2024
March 14 (Reuters) - Cleveland-Cliffs Inc ( CLF ) would consider another bid for United States Steel ( X ), provided it has union backing, but it would be significantly lower than Nippon Steel's ( NISTF ) current offer, Bloomberg News reported on Thursday. US Steel and Cleveland-Cliffs ( CLF ) did not immediately respond to Reuters' requests for comments....
US FDA approves first drug for fatty liver disease NASH
US FDA approves first drug for fatty liver disease NASH
Mar 14, 2024
March 14 (Reuters) - The U.S. FDA has approved Madrigal Pharmaceuticals' ( MDGL ) drug for a fatty liver disease known as non-alcoholic steatohepatitis (NASH), the first treatment to get the nod for the condition and opening up a multi-billion opportunity. The company's oral drug, called Rezdiffra, has been approved for patients who have NASH with fibrosis, or scarring, that...
Venture Global LNG asks US energy regulator to keep documents confidential
Venture Global LNG asks US energy regulator to keep documents confidential
Mar 14, 2024
HOUSTON, March 14 (Reuters) - Liquefied natural gas (LNG) exporter Venture Global LNG on Thursday delivered to U.S. regulators a proposed protective order seeking to keep documents on the construction of a Louisiana export facility confidential. The request will test the Federal Energy Regulatory Commission's (FERC) willingness to back a call by Venture Global LNG's customers to require the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved